Article info

Download PDFPDF
ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl

Authors

  • W. Xu Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • B. Cai Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • J. L. Chen Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • L. X. Li Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • J. R. Zhang Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Y. Y. Sun Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • X. P. Wan Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to: Xiaoping Wan, MD, PhD, Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated First People's Hospital, No. 85 Wujin Road, Shanghai 200080, People's Republic of China. Email: wanxiaoping61{at}126.com

Citation

Xu W, Cai B, Chen JL, et al
ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl

Publication history

  • First published July 1, 2008.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.